Endocrinology, Diabetes and Metabolism Journal Publishes Scientific Paper Authored by Oramed Scientists
JERUSALEM, Oct. 17, 2017 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today the publication of a new paper co-authored by Oramed’s Chief Scientific Officer, Dr. Miriam Kidron, Dr. Roy Eldor, Dr. Ehud Arbit and Dr. Yael Greenberg-Shushlav. The paper, “Additive Effect of […]
